Ocular Surface Disease

Welcome to another edition of CEDARS/ASPENS Debates. CEDARS/ASPENS is a society of cornea, cataract and refractive surgery specialists, here to discuss some of the latest hot topics in ophthalmology.

NovaBay Pharmaceuticals announced the launch of a prescription optic allograft for protecting the ocular surface, made with BioStem Technologies’ proprietary process.

WASHINGTON — Biovance 3L Ocular human amniotic membrane allograft improved best corrected visual acuity and symptoms of eye dryness in a small cohort of patients, according to a poster presentation at Optometry’s Meeting.

Eye care providers consider scleral lenses to be a first-choice treatment for patients with corneal irregularity, although the lenses were not favored for ocular surface disease, according to a study published in Eye & Contact Lenses.

Healio spoke with I. Paul Singh, MD, about dry eye prevention tips to discuss with patients.

Healio spoke with I. Paul Singh, MD, about risk factors for developing dry eye, particularly in women.

Healio spoke with I. Paul Singh, MD, about recent new treatment options in dry eye.

Healio spoke with I. Paul Singh, MD, about recent advancements in the treatment of dry eye and other ocular surface diseases.

In this video, Ronald L. Benner, OD, discusses unmet needs in dry eye.

One of the biggest challenges in dry eye care has always been getting the primary eye care population interested in treating ocular surface disease.